Aryloxypropanolamine targets amyloid aggregates and reverses Alzheimer-like phenotypes in Alzheimer mouse models.
Lee HY, Yoon S, Lee JH, Park K, Jung Y, Cho I, Lee D, Shin J, Kim K, Kim S, Kim J, Kim K, Han SH, Kim SM, Kim HJ, Kim HY, Kim I, Kim YS.
Lee HY, et al. Among authors: kim hy, kim hj, kim s, kim sm, kim ys, kim j, kim i, kim k.
Alzheimers Res Ther. 2022 Nov 29;14(1):177. doi: 10.1186/s13195-022-01112-6.
Alzheimers Res Ther. 2022.
PMID: 36443837
Free PMC article.